Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Capital Group Holdings, Inc. (CGHC)
Scottsdale, AZ, US
Capital Group Holdings, Inc. delivers a range of health and wellness solutions throughout the United States. A key offering is OneHealthPass, their online personal health record system, which enables the seamless exchange of documents, images, and voicemails via multiple channels, including fax, voice, and direct file uploads. The company further provides patient-focused telehealth services and oversees seven urgent care facilities that offer medical treatment across the Phoenix, Arizona metropolitan area. Founded in 1980, the organization, initially known as Oasis Online Technologies, Corp., adopted the Capital Group Holdings, Inc. name in April 2010 and is headquartered in Scottsdale, Arizona.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -37.50% | -37.50% | -98.89% | -99.09% | -99.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%+89.3% ★ Q1'13: -118.5% (vs Q1'12)
-
FCF margin FCF growth · Medical - Devices: +30.9%— Q1'13: -2.4% (vs Q1'12)
-
EBIT margin Medical - Devices: +6.2%— Q1'13: -23.6% (vs Q1'12)
-
ROIC Medical - Devices: +3.3%— Q1'13: -18.9% (vs Q1'12)
-
Share dilution Medical - Devices: 0.0%+35.9% Q1'13: +53.3% (vs Q1'12)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.01× Q1'13: -1.14× (vs Q1'12)
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Blumhoff | Chairman & Chief Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CGHC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
